Ain Holdings adopts poison pill to block Oasis Management from increasing stake — BigGo Finance

Ain Holdings (9627.T), Japan’s largest dispensing pharmacy chain, announced on the 25th that it will introduce a response policy to large-scale share purchases in response to the rapid and substantial accumulation of its shares by Hong Kong-based investment fund Oasis Management. If Oasis, including its joint holders, moves to increase its voting-rights-based stake beyond 22.24%, the company will demand an explanation of the rationale, scrutinize the response, and, if necessary, convene an extraordinary general meeting of shareholders to seek approval for triggering the countermeasure.

According to the Large Shareholding Report, Oasis’s stake in Ain Holdings reached 22.24% as of August 19. Since it stood at 16.68% as of April 27, Oasis has increased its stake by more than 5.5 percentage points in roughly four months. Oasis currently describes the reason for its stake increase as a “pure investment,” but Ain Holdings has pointed out that the information necessary for shareholders to judge the purpose and details of the share acquisition has not been disclosed. The company stated that further share accumulation may occur, and if so, it could have a serious impact on mid- to long-term corporate value and shareholder interests.

The specific countermeasure under the policy is dilution through the free allocation of share subscription rights. If a majority of shareholders approve the countermeasure against the stake increase and Oasis does not withdraw its purchase plan, the company will issue share subscription rights to shareholders free of charge to reduce Oasis’s voting rights ratio. If Oasis fails to provide an explanation, the same countermeasure can be triggered without going through a shareholder meeting.

The effective period of the response policy is set to run until the conclusion of the first board of directors meeting held after the annual general meeting of shareholders scheduled to be held by the end of July 2027. Ain Holdings explained that this measure is intended to demand that Oasis provide the information necessary for shareholders to make informed decisions, to evaluate the proposal at the board level, to engage in negotiations, and to secure the time necessary for shareholders to judge the merits of the large-scale share purchase.

Background of the Share Accumulation

The changes in Oasis’s stake in Ain Holdings are as follows.

Note: Based on the Large Shareholding Report. Includes joint holders.

Oasis is an activist investment fund based in Hong Kong with an extensive track record of investing in Japanese companies. It has previously invested in companies such as Toshiba and Kao, pushing for improvements in corporate value through dialogue with management and shareholder proposals. The market is aware that the current accumulation of Ain Holdings shares could lead to some form of demand regarding the company’s management strategy or capital policy.

Key Focus Going Forward

The countermeasure introduced by Ain Holdings is a type of so-called poison pill, a defensive measure against hostile takeovers and large-scale share purchases that has been adopted by other listed Japanese companies. However, a distinctive feature is that it is designed to respect shareholder will, with shareholder meeting approval required in principle for triggering the measure.

The key focus going forward is what demands or proposals Oasis will make to Ain Holdings. While Oasis describes its position as a “pure investment,” Ain Holdings has countered that information disclosure is insufficient, and the conflict between the two sides could deepen. Attention will be focused on whether Oasis continues to increase its stake or attempts to pressure management through shareholder proposals.

Ain Holdings is the industry’s largest player, operating dispensing pharmacies nationwide and expanding its scale through M&A (mergers and acquisitions). The market has speculated that Oasis may demand measures to enhance corporate value, such as a review of the business portfolio, expansion of share buybacks, or a refresh of the management team. Following the announcement on the 25th, the company’s share price may experience volatile trading for some time due to assessments of the takeover defense measure and uncertainty over Oasis’s next move.